Csernansky J G, Prosser E, Kaplan J, Mahler E, Berger P A, Hollister L E
Biol Psychiatry. 1986 Jun;21(7):632-42. doi: 10.1016/0006-3223(86)90124-1.
To determine whether there is an association between prolactin (PRL) levels and psychopathology or tardive dyskinesia during neuroleptic treatment, we measured plasma prolactin levels and neuroleptic activity (NA) in 33 chronically treated male schizophrenics. Neuroleptic dose, plasma NA, and PRL were significantly intercorrelated. Plasma PRL levels were also measured in 8 male schizophrenics recently withdrawn from neuroleptics and in 18 normal male controls. In treated patients, but not in controls, PRL levels decreased with age and duration of illness, two variables that we interpreted as indirect measures of neuroleptic exposure. PRL levels in patients recently withdrawn from neuroleptics were lower than in treated patients or controls, which was suggestive of rebound hypoprolactinemia. A prolactin index, calculated as the ratio of PRL levels to NA, was inversely correlated with paranoid symptoms and tardive dyskinesia in younger treated patients. These results lead to speculation that tuberoinfundibular dopaminergic supersensitivity develops in chronically treated schizophrenics and that it is associated with nigrostriatal supersensitivity, manifested by tardive dyskinesia, and paranoid symptoms, which may reflect mesolimbic supersensitivity.
为了确定在抗精神病药物治疗期间催乳素(PRL)水平与精神病理学或迟发性运动障碍之间是否存在关联,我们测量了33例长期接受治疗的男性精神分裂症患者的血浆催乳素水平和抗精神病药物活性(NA)。抗精神病药物剂量、血浆NA和PRL之间存在显著的相互关联。我们还测量了8例近期停用抗精神病药物的男性精神分裂症患者以及18名正常男性对照者的血浆PRL水平。在接受治疗的患者中,而非对照者中,PRL水平随年龄和病程的增加而降低,我们将这两个变量解释为抗精神病药物暴露的间接指标。近期停用抗精神病药物的患者的PRL水平低于接受治疗的患者或对照者水平,这提示存在催乳素血症反跳。催乳素指数(计算为PRL水平与NA的比值)与年轻接受治疗患者的偏执症状和迟发性运动障碍呈负相关。这些结果引发了这样的推测:在长期接受治疗的精神分裂症患者中会出现结节漏斗多巴胺能超敏反应,并且它与黑质纹状体超敏反应相关,表现为迟发性运动障碍和偏执症状,这可能反映了中脑边缘系统超敏反应。